HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa A Fortier Selected Research

procollagen type II carboxy-terminal peptide

1/2020Integrin α10β1-Selected Mesenchymal Stem Cells Mitigate the Progression of Osteoarthritis in an Equine Talar Impact Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa A Fortier Research Topics

Disease

13Osteoarthritis
12/2021 - 10/2011
8Wounds and Injuries (Trauma)
12/2021 - 05/2002
7Inflammation (Inflammations)
12/2021 - 06/2009
6Pain (Aches)
10/2021 - 05/2002
5Stress Fractures (Stress Fracture)
12/2021 - 08/2010
2Pathologic Processes
10/2021 - 08/2013
2Knee Osteoarthritis
01/2019 - 02/2017
2Arthritis (Polyarthritis)
01/2018 - 10/2011
1Cartilage Diseases (Cartilage Disease)
02/2022
1Arthralgia (Joint Pain)
12/2021
1Osteolysis
10/2021
1Hallux Rigidus
10/2021
1Foreign Bodies (Foreign Body)
10/2021
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Sclerosis
01/2020
1Fibrosis (Cirrhosis)
01/2019
1Synovitis
01/2019
1Infections
01/2019
1Ankle Injuries (Ankle Injury)
01/2017
1Athletic Injuries (Sports Injuries)
01/2017
1Musculoskeletal Diseases (Musculoskeletal Disease)
01/2014
1Teratoma (Teratoid Tumor)
08/2012
1Tendinopathy (Tendonitis)
05/2010
1Soft Tissue Injuries (Soft Tissue Injury)
05/2010
1type 2 alpha 1 Collagenopathy
06/2006
1Joint Diseases (Joint Disease)
12/2005
1Urolithiasis
11/2004
1Postoperative Pain
05/2002
1Infectious Arthritis (Septic Arthritis)
05/2002

Drug/Important Bio-Agent (IBA)

4CollagenIBA
02/2022 - 08/2010
4Biological ProductsIBA
12/2021 - 01/2017
4GlycosaminoglycansIBA
10/2021 - 06/2006
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 05/2010
2Aggrecans (Aggrecan)IBA
02/2022 - 06/2006
2RNA (Ribonucleic Acid)IBA
12/2021 - 06/2006
2Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2020
2Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2017
2Collagen Type II (Type II Collagen)IBA
01/2020 - 08/2010
2Hyaluronic Acid (Hyaluronan)IBA
02/2017 - 02/2015
1Formaldehyde (Formol)FDA Link
12/2021
1ParaffinIBA
12/2021
1Polyvinyl AlcoholIBA
10/2021
1polyvinyl alcohol hydrogelIBA
10/2021
1HydrogelsIBA
10/2021
1Dinoprostone (PGE2)FDA Link
01/2020
1procollagen type II carboxy-terminal peptideIBA
01/2020
1IntegrinsIBA
01/2020
1lubricinIBA
01/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1LubricantsIBA
01/2018
1CytokinesIBA
12/2015
1Polyglycolic Acid (Polyglycolide)IBA
02/2015
1Telomerase (Telomerase Reverse Transcriptase)IBA
10/2014
1Doxycycline (Periostat)FDA LinkGeneric
08/2012
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2011
1Transforming Growth Factors (Transforming Growth Factor)IBA
10/2011
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2011
1Platelet-Derived Growth FactorIBA
10/2011
1Indicators and Reagents (Reagents)IBA
06/2009
1Thiobarbituric Acid Reactive SubstancesIBA
06/2009
1Troponin IIBA
06/2009
1Creatine Kinase (Creatine Phosphokinase)IBA
06/2009
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2009
1Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2009
1Matrix Metalloproteinases (MMPs)IBA
06/2006
1Morphine (MS Contin)FDA LinkGeneric
05/2002
1detomidineIBA
05/2002

Therapy/Procedure

9Therapeutics
01/2020 - 12/2005
2Injections
12/2021 - 12/2021
2Arthrodesis
10/2021 - 02/2010
1Hemiarthroplasty
10/2021
1Viscosupplementation
12/2020
1Meniscectomy
01/2019
1Bone Wires
10/2016
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2016
1Osteotomy
01/2016
1Orthopedic Procedures
12/2013
1Conservative Treatment
08/2013
1Anterior Cruciate Ligament Reconstruction
05/2010
1Semiconductor Lasers
02/2010
1Cystostomy (Suprapubic Cystostomy)
11/2004